Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy. [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating the safety and tolerability of GEN6050X in Duchenne muscular dystrophy, with the trial currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• GEN6050X

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Duchenne Muscular Dystrophy (DMD) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING